Silver Book Fact

Investments in cancer care generated $598 billion of additional value for cancer patients diagnosed between 1983 and 1999.

Philipson T, Eber M, Lakdawalla D, Corral M, et al. An Analysis of Whether Higher Health Care Spending is Worth it in the Case of Cancer. Health Affairs. 2012; 31(4): 667-75. http://content.healthaffairs.org/content/31/4/667.abstract

Reference

Title
An Analysis of Whether Higher Health Care Spending is Worth it in the Case of Cancer
Publication
Health Affairs
Publication Date
2012
Authors
Philipson T, Eber M, Lakdawalla D, Corral M, et al.
Volume & Issue
Volume 31, Issue 4
Pages
667-75
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • According to the Pharmaceutical Research and Manufacturers of America, a cancer medicine in development is designed to induce a powerful immune response to melanoma.  
  • Investments in cancer research and development between 1998 and 2000 has generated 23 million additional healthy years of life and $1.9 trillion of additional social value.  
  • When detected early, the 5-year survival rate for colorectal cancer is 90%; however, only 39% of colorectal cancers are diagnosed early, mainly because of low rates of screening.  
  • Treating cancer patients with oral medicine versus intravenous chemotherapy results in a 2/3 reduction in hospital time and a greater than 50% reduction in costly medication side effects.  
  • Improvement in 5-Year Survival Rates for All Cancers Since 1975